Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $27.77, with a market capitalization of 158.53B. The stock trades at a price-to-earnings (P/E) ratio of 37.39 and offers a dividend yield of 6.09%.
On 2026-08-20, Pfizer(PFE) stock traded between a low of $27.65 and a high of $28.17. Shares are currently priced at $27.77, which is +0.5% above the low and -1.4% below the high.
The Pfizer(PFE)'s current trading volume is 29.3M, compared to an average daily volume of 39.64M.
During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.
During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.
PFE News
The most widely read finance newsletter on Substack isn't published by a bank, it's Doomberg , where 383,000+ readers get the energy and macro analysis the main...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip By Joey Frenette Published Aug 20, 11:34AM EDT Quick...
Analyst ratings
62%
of 29 ratingsMore PFE News
Pfizer (NYSE:PFE) has reached a settlement program intended to resolve a major portion of federal Depo-Provera intracranial meningioma lawsuits. The program ta...
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? By David Moadel Published Aug 19, 3:20PM EDT Quick Read Merck surged 44% YTD, topping Am...
Pfizer (PFE) stock was up 3.74% on Wednesday, despite a lack of news from the biopharmaceutical company. However, that doesn’t mean that PFE stock was up withou...
Key Points Its current dividend yield is sizeable, and based on a dividend with more resiliency than the market’s presuming. Most drugs have more of a defensi...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...
With global bond yields high and borrowing costs less forgiving, capital is flowing toward companies that can raise productivity rather than just cut expenses....
Pfizer stock has returned roughly 28.4% less over the past five years, yet the current valuation screens as somewhat expensive on market multiples and only mixe...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.